Mannitol Fresenius

Mannitol, the active ingredient in Mannitol Fresenius, is an osmotic diuretic presented as an intravenous solution for intravenous use. It is employed to reduce cerebral edema, manage increased intracranial pressure, treat acute renal failure, and lower intra‑ocular pressure in glaucoma.

GNH USA supplies Mannitol Fresenius as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Mannitol acts as an osmotic agent to manage fluid‑related conditions in the brain, eye and kidneys.

- Cerebral edema: reduces brain swelling by drawing fluid into the vascular compartment. - Increased intracranial pressure: lowers pressure within the skull, helping to prevent herniation. - Acute renal failure: promotes diuresis to assist renal clearance of waste products. - Glaucoma: decreases intra‑ocular pressure by increasing aqueous humor outflow.

Mannitol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate discomfort. - Nausea or vomiting: gastrointestinal upset. - Thirst or dry mouth: increased fluid demand. - Electrolyte disturbances: mild hyponatremia or hypokalemia.

Serious or Rare Side Effects: - Pulmonary edema: fluid accumulation in the lungs. - Severe allergic reaction: rash, itching, or anaphylaxis. - Renal tubular necrosis: impaired kidney function. - Cardiac arrhythmia: abnormal heart rhythm.

Before administering Mannitol, consider the following safety measures.

- Monitor fluid balance: track input and output to avoid overload. - Check serum electrolytes: correct imbalances prior to infusion. - Adjust dose in renal impairment: reduced clearance may require lower amounts. - Use cautiously in heart failure: risk of fluid shifts and worsening symptoms. - Avoid rapid infusion rates: administer over the recommended time to limit hypotension. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mannitol can interact with other medications, affecting safety and efficacy.

Major Interactions (Avoid): - Loop diuretics: additive diuretic effect may cause severe electrolyte loss. - Lithium: increased lithium levels and risk of toxicity. - Insulin or oral hypoglycemics: may enhance hypoglycemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may potentiate renal effects and affect blood pressure. - Antihypertensives: additive blood‑pressure‑lowering effect requires monitoring.